Citadel Advisors - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$15,000
+7.1%
27,782
+75.1%
0.00%
Q4 2015$14,000
+16.7%
15,864
+11.1%
0.00%
Q3 2015$12,000
-58.6%
14,276
+46.2%
0.00%
Q2 2015$29,000
-88.9%
9,763
-90.9%
0.00%
Q1 2015$262,000
-96.0%
106,928
-95.8%
0.00%
-100.0%
Q4 2014$6,568,000
-71.8%
2,575,572
-20.9%
0.01%
-75.0%
Q3 2014$23,263,000
+4515.7%
3,258,099
+4107.6%
0.02%
+2300.0%
Q2 2014$504,000
+362.4%
77,434
+368.7%
0.00%
Q1 2014$109,00016,5220.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 1,320,000$9,425,00010.46%
RA Capital Management 4,869,261$34,767,0004.11%
GREAT POINT PARTNERS LLC 400,000$2,856,0001.23%
Healthcare Value Capital, LLC 100,000$714,0000.69%
DSC Advisors, L.P. 175,000$1,250,0000.63%
Quantitative Systematic Strategies LLC 107,416$803,0000.47%
Visium Asset Management, LP 4,093,890$29,230,0000.43%
Rhenman & Partners Asset Management AB 201,171$1,436,0000.42%
EAM Investors, LLC 277,807$1,984,0000.40%
ESSEX INVESTMENT MANAGEMENT CO LLC 354,861$2,534,0000.39%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders